An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)

• DOI: 10.1007/s00394-018-1785-z
• Publication Date: 2018-08-03T15:00:56Z
• Authors: Mariadelina Simeoni; Maria Lucia Citraro; Annamaria Cerantonio; Francesca Deodato; Michele Provenzano; Paola Cianfrone; Maria Capria; Silvia Corrado; Emanuela Libri; Alessandro Comi; Arturo Pujia; Ludovico Abenavoli; Michele Andreucci; Massimo Cocchi; Tiziana Montalcini; Giorgio Fuiano
• Keywords: Dysbiosis; Transferrin saturation

Gut dysbiosis has been described in advanced, but not initial stages of CKD. Considering the relevant impact gut on renal and cardiovascular risk, its diagnosis treatment are clinically relevant.